Integrated control of proliferation and differentiation of mesenchymal stem cells
- PMID: 2647473
- PMCID: PMC1567618
- DOI: 10.1289/ehp.8980117
Integrated control of proliferation and differentiation of mesenchymal stem cells
Abstract
The physiological control of cellular proliferation and differentiation is an integrated regulatory process. This conclusion is based upon observations using numerous in vivo and in vitro experimental systems of which murine BALB/c 3T3 T mesenchymal stem cells represent an excellent in vitro model. In these cells the coupling of growth arrest and differentiation occurs at a distinct biological state, and this predifferentiation arrest state is distinguishable by a variety of criteria from other restriction points, such as the growth factor deficiency arrest state and the nutrient deficiency arrest state. Most importantly, only cells at this predifferentiation arrest state acquire the potential to differentiate without undergoing DNA synthesis. From this state, differentiation can then occur as a two-step process. Cells first undergo nonterminal differentiation and, second, they terminally differentiate. Nonterminal differentiation is characterized by expression of a completely differentiated adipocyte phenotype with retention of proliferative potential. Thereafter, when nonterminally differentiated cells undergo the terminal event in differentiation, they irreversibly lose their proliferative potential. In this paper, data are reviewed which establish that the integrated control of proliferation and differentiation in 3T3 T mesenchymal stem cells is mediated both at the predifferentiation arrest state and at the state of nonterminal differentiation.
Similar articles
-
Specific expression of proteins and phosphoproteins in 3T3 T mesenchymal stem cells at distinct growth arrest and differentiation states.Cell Tissue Kinet. 1990 Mar;23(2):71-87. doi: 10.1111/j.1365-2184.1990.tb01334.x. Cell Tissue Kinet. 1990. PMID: 2317836
-
Inhibition of distinct steps in the adipocyte differentiation pathway in 3T3 T mesenchymal stem cells by dimethyl sulphoxide (DMSO).Cell Prolif. 1993 Jan;26(1):55-66. doi: 10.1111/j.1365-2184.1993.tb00006.x. Cell Prolif. 1993. PMID: 8439589
-
Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.Cancer Res. 1986 Oct;46(10):5312-9. Cancer Res. 1986. PMID: 3756880
-
Differentiation, cancer, and anticancer activity.Biochem Cell Biol. 1988 Jun;66(6):478-89. doi: 10.1139/o88-060. Biochem Cell Biol. 1988. PMID: 3048326 Review.
-
Aproliferin: a modulator of proliferative potential.Biofactors. 1988 Jul;1(2):129-31. Biofactors. 1988. PMID: 3076440 Review.
Cited by
-
Porcine G₀/G₁ switch gene 2 (G0S2) expression is regulated during adipogenesis and short-term in-vivo nutritional interventions.Lipids. 2013 Mar;48(3):209-18. doi: 10.1007/s11745-013-3756-8. Epub 2013 Jan 16. Lipids. 2013. PMID: 23322075
-
Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control.Microbiol Rev. 1991 Sep;55(3):512-42. doi: 10.1128/mr.55.3.512-542.1991. Microbiol Rev. 1991. PMID: 1943999 Free PMC article. Review.
-
Prostate Cancer Phenotype Influences Bone Mineralization at Metastasis: A Study Using an In Vitro Prostate Cancer Metastasis Testbed.JBMR Plus. 2019 Dec 30;4(2):e10256. doi: 10.1002/jbm4.10256. eCollection 2020 Feb. JBMR Plus. 2019. PMID: 32083238 Free PMC article.
-
Identification of Pathways Mediating Growth Differentiation Factor5-Induced Tenogenic Differentiation in Human Bone Marrow Stromal Cells.PLoS One. 2015 Nov 3;10(11):e0140869. doi: 10.1371/journal.pone.0140869. eCollection 2015. PLoS One. 2015. PMID: 26528540 Free PMC article.
-
Unique and selective mitogenic effects of vanadate on SV40-transformed cells.Mol Cell Biochem. 1995 Dec 6-20;153(1-2):59-67. doi: 10.1007/BF01075919. Mol Cell Biochem. 1995. PMID: 8927049 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical